|Articles|January 27, 2021

Supplements and Featured Publications

  • Value-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis

Value-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis

The American Journal of Managed Care® hosted a scientific interchange titled “Value-Based Agreements in Rare Disease” on September 30, 2020. This publication highlights key discussion points and insights from this event.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo